Loading
AT
Aimmune Therapeutics, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Societe des Produits Nestle S.A., was filed 15 Oct 2020.
Aimmune Therapeutics, Inc.: what insiders have been doing
Every trade that managers of Aimmune Therapeutics, Inc. disclose to SEC (Form 4) is tracked on this page. Nothing new has been filed by managers of Aimmune Therapeutics, Inc. in twelve months, the latest record being from 15 October 2020.
Looking back to 2016, when coverage begins, insiders filed 27 purchases and 101 sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
303
Thresholds
n/a
Buy Volume
€2B
27 ops. · all time
Sell Volume
€36M
101 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2019FY ended December 2019 · cache
Income statement
Net income-221.5M
Last declaration on 15 October 2020
Declarations303 total
43,435,583 shares@ US$34.5062.6% of flowCommon StockSEC:0000899243-20-028359:0
Canonical exit: 11 Jan 2021 (T+90)
10,681,704 shares@ US$34.5015.4% of flowCommon StockSEC:0000899243-20-028359:1
Canonical exit: 11 Jan 2021 (T+90)
65,192 shares@ US$34.5045.6% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028172:0
69,894 shares@ US$34.5048.9% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028172:1
7,840 shares@ US$34.505.5% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028172:2
70,561 shares@ US$34.5033.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028173:0
91,697 shares@ US$34.5042.9% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028173:1
7,840 shares@ US$34.503.7% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028173:2
39,567 shares@ US$34.5083.4% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028174:0
7,840 shares@ US$34.5016.6% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028174:1
27,805 shares@ US$34.5047.9% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028176:0
23,905 shares@ US$34.5041.3% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028176:1
10,221 shares@ US$34.5056.5% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028177:0
7,840 shares@ US$34.5043.5% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028177:1
6,250 shares@ US$34.5031.9% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028178:0
13,313 shares@ US$34.5068.1% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028178:1
7,840 shares@ US$34.50100.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028179:1
26,852 shares@ US$34.5077.4% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028180:0
7,840 shares@ US$34.5022.6% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028180:1
47,450 shares@ US$34.5047.3% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028182:0
36,875 shares@ US$34.5036.8% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028182:1
30,422 shares@ US$34.5023.5% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028181:0
89,250 shares@ US$34.5069.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028181:1
6,345 shares@ US$34.5021.1% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028183:0
20,250 shares@ US$34.5067.5% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028183:1
25 of 303 declarations
About Aimmune Therapeutics, Inc.
Aimmune Therapeutics, Inc. is a biopharmaceutical company focused on developing treatments for food allergies. It is listed on the NASDAQ under the ticker AIMT.
